NASDAQ

Ultragenyx Reports First Quarter 2016 Financial Results and Corporate Update

NOVATO, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical ...

Fate Therapeutics Reports First Quarter 2016 Financial Results

Phase 1/2 Clinical Trial of ProTmune™ for Prevention of Acute GvHD and CMV Infection ...

Launch and pricing of EUR2.2bn bond issues

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD ...

Antibiotic Against Superbug Biofilms, RSV

PITTSBURGH, May 9, 2016 (GLOBE NEWSWIRE) -- via PRWEB - A potential drug therapy ...

Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results

PLYMOUTH MEETING, Pa., May 09, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

Karyopharm Reports First Quarter 2016 Financial Results and Highlights Recent Progress

Phase 2/3 SEAL Clinical Trial Initiated with Selinexor for Treatment of Liposarcoma First-in-Human Study ...